2002
DOI: 10.1001/archpedi.156.5.485
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Starting Dose of Levothyroxine for the Treatment of Congenital Hypothyroidism

Abstract: The evidence for an effect of starting dose of levothyroxine on cognitive development, growth, or behavior is too weak to justify recommendations in favor of high- or standard-dose regimens. More reliable information, based on a randomized controlled trial of starting dose or a meta-analysis of the individual patient data currently available, is required to inform treatment policies.

Search citation statements

Order By: Relevance

Paper Sections

Select...
43
9
4
1

Citation Types

2
34
0
2

Year Published

2002
2002
2023
2023

Publication Types

Select...
43
8
4

Relationship

0
55

Authors

Journals

citations

Cited by 55 publications

(38 citation statements)
references

References 53 publications

2
34
0
2
Order By: Relevance
How this paper cites the one you are viewing
“…Moreover long-term follow-up studies found that high starting dose of L-T4 might cause more behavior problems reflecting increased anxiety, social withdrawal, and poorer concentration (Rovet and Ehrlich, 1995;Oerbeck et al, 2003). The starting dose of L-T4 we used is in conformity with what Campos and Rovet reported, but is much lower than the commonly used dose of 8~15 µg/(kg·d) or the 10.1~15.0 µg/(kg·d) reported from previous studies (Gruters et al, 1997;Hrytsiuk et al, 2002;Salerno et al, 2002). Patients with permanent CH require long-term substitution with a large dose of thyroxin (Rovet and Ehrlich, 1995).…”
Section: Discussion
supporting
confidence: 79%